FAM98A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.770600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.002200E-01
Normal-vs-Stage2
3.353800E-02
Normal-vs-Stage3
8.143000E-01
Normal-vs-Stage4
9.031900E-02
Stage1-vs-Stage2
7.392600E-01
Stage1-vs-Stage3
3.644800E-01
Stage1-vs-Stage4
3.908800E-01
Stage2-vs-Stage3
3.306400E-01
Stage2-vs-Stage4
2.112000E-01
Stage3-vs-Stage4
1.683410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.454200E-02
Normal-vs-AfricanAmerican
2.348000E-01
Normal-vs-Asian
6.753000E-01
Caucasian-vs-AfricanAmerican
5.146800E-01
Caucasian-vs-Asian
6.381400E-01
AfricanAmerican-vs-Asian
3.127400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.392000E-02
Normal-vs-Female
5.273600E-01
Male-vs-Female
7.927400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.577200E-01
Normal-vs-Age(41-60Yrs)
3.238600E-01
Normal-vs-Age(61-80Yrs)
1.776640E-01
Normal-vs-Age(81-100Yrs)
4.549200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.436800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.612000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.932000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.941500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.733200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.307200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.773000E-01
Normal-vs-Daily Drinker
8.548800E-01
Normal-vs-Weekly Drinker
5.489700E-02
Normal-vs-Occasional Drinker
7.742000E-01
Normal-vs-Social Drinker
2.433600E-02
Non Drinker-vs-Daily Drinker
4.986400E-01
Non Drinker-vs-Weekly Drinker
7.887600E-02
Non Drinker-vs-Occasional Drinker
8.492600E-01
Non Drinker-vs-Social Drinker
4.777600E-02
Daily Drinker-vs-Weekly Drinker
2.771500E-02
Daily Drinker-vs-Occasional Drinker
3.897400E-01
Daily Drinker-vs-Social Drinker
1.401660E-02
Weekly Drinker-vs-Occasional Drinker
1.215430E-01
Weekly Drinker-vs-Social Drinker
9.249400E-01
Occasional Drinker-vs-Social Drinker
7.558400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.077800E-01
Normal-vs-Grade 2
9.666400E-01
Normal-vs-Grade 3
9.913600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.330210E-02
Grade 1-vs-Grade 3
7.804000E-02
Grade 1-vs-Grade 4
9.077800E-01
Grade 2-vs-Grade 3
5.530400E-01
Grade 2-vs-Grade 4
9.666400E-01
Grade 3-vs-Grade 4
9.913600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.701850E-01
Normal-vs-NonDiabetic
6.968800E-01
Diabetic-vs-NonDiabetic
6.488000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.120600E-01
Normal-vs-NoPancreatitis
1.053840E-01
Pancreatitis-vs-NoPancreatitis
6.714000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.774950E-01
Normal-vs-N1
5.118600E-01
N0-vs-N1
4.123600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.327600E-01
Normal-vs-TP53-NonMutant
7.567000E-01
TP53-Mutant-vs-TP53-NonMutant
9.424600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
